Erina Sakamoto

SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets

Shigekazu Murakami, Wataru Ninomiya, Erina Sakamoto et al. · Stem Cells · 2015 · 79 citations

Medicine, Cell Biology, Oncology +17

Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2

Erina Sakamoto, Fumihiko Hato, Takayuki Kato et al. · Journal of Leukocyte Biology · 2005 · 70 citations

Life Sciences, Cell Biology, Immunology +17

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma

Yoshiki Terada, Hirohisa Nakamae, Ran Aimoto et al. · Journal of Experimental & Clinical Cancer Research · 2009 · 69 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Selective activation of STAT3 in human monocytes stimulated by G-CSF: implication in inhibition of LPS-induced TNF-α production

Saori Nishiki, Fumihiko Hato, Noriko Kamata et al. · American Journal of Physiology-Cell Physiology · 2004 · 63 citations

Life Sciences, Immunology, Cell Signaling +14

Analysis of elderly patients with diffuse large B‐cell lymphoma: aggressive therapy is a reasonable approach for ‘unfit’ patients classified by comprehensive geriatric assessment

Masahiro Yoshida, Takafumi Nakao, Mirei Horiuchi et al. · European Journal Of Haematology · 2015 · 42 citations

Medicine, Geriatric Medicine, Oncology +17